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Degenerative cervical myelopathy (DCM) is a common non-traumatic spinal cord disorder and characterized by progressive
neurological impairment. Generally, it is still underdiagnosed and referral to spine specialists is often late, when patients already
present with incomplete cervical spinal cord injury (SCI). To improve early diagnosis and accelerate referral, diagnostic criteria for
DCM are required. Recently, AO Spine RECODE- DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical
Myelopathy) (aospine.org/recode), an international, interdisciplinary and interprofessional initiative, including patients with DCM,
was funded with the aim to accelerate knowledge discovery that can change outcomes. In this perspective we advocate for the
participation of SCI specialists in this process, where the expertise and perspective on this disorder and requirements for the
diagnostic and therapeutic work up is well developed.
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PERSPECTIVE
Degenerative cervical myelopathy (DCM) (historically termed
“cervical spondylotic myelopathy” [CSM]) is the most common
non-traumatic, progressive spinal cord disorder with an estimated
2% prevalence [1]. The disorder is indeed imprecisely and
insufficiently characterized by neck and radicular pain, fine motor
dysfunction, gait instability, and bladder dysfunction and for most
lacks common diagnostic criteria [2]. If not recognized and treated
timely, patients may eventually present as incomplete cervical
spinal cord injury (SCI). This letter aims to raise awareness of these
shortcomings in the neurological community and emphasize
an ongoing initiative to improve clinical care and foster
global research [3]. The neurological field should not be left out
in this effort.
Due to a variety of symptoms, patients eventually get referred
to different specialists, commonly orthopedics, neurosurgeons,
neurologists, or physiotherapists. While surgical decompression of
the encroached spinal cord is recommended in patients
experiencing already moderate/severe, or progressive symptoms,
the goal of enabling earlier and/or preventative treatment has
now been defined as a priority research need. In its early stages,
DCM is frequently underdiagnosed or misdiagnosed as carpal
tunnel syndrome or peripheral neuropathy, until patients develop
more severe impairments of upper and lower limb function urging
the consideration of incomplete cervical SCI. Given that DCM is a
progressive but preventable neurological condition, the delayed
diagnosis and late referral for evaluation of surgical decompres-
sion, can lead to poorer neurological outcomes [4]. In addition, the
pre-operative neurological status significantly influences post-
operative recovery [5]. Therefore, an early diagnosis is important
to achieve good clinical results. The diagnosis of DCM is currently
based on clinical signs and symptoms, eventually complemented
by cervical spine MRI. However, there is still no consensus on
diagnostic criteria for DCM, leading to ambiguous, descriptive
clinical diagnoses, and heterogenous definitions of DCM applied
in clinical studies [6, 7]. Furthermore, as demonstrated in the UK,
DCM is rarely covered in the medical curriculum [8]. AO Spine
RECODE-DCM (REsearch Objectives and Common Data Elements
for Degenerative Cervical Myelopathy) (aospine.org/recode) is an
international, interdisciplinary, and interprofessional initiative,
including patients with DCM, which aims to accelerate knowledge
discovery that can change outcomes [9]. This has included the
formation of research priorities such as the development of
common diagnostic criteria. Alongside its importance for clinical
care, a sensitive and specific set of diagnostic criteria is required to
foster research, particularly for those studies aiming at investigat-
ing neuroprotective strategies. Diagnostic criteria for DCM can
help to overcome several shortcomings in patient care and
research (Fig. 1). The development of diagnostic criteria for DCM
would benefit from the experiences of the neurological commu-
nity; a UK cohort study identified 45% of cases are initially
diagnosed by Neurologists, whilst Neurologists are familiar with
their development and implementation [10]. Common criteria will
help the dialog between neurologists, general practitioners
(primary care providers), and spine specialists, and propagate
the knowledge of red flags in DCM that require timely and specific
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actions, before established SCI. The development of diagnostic
criteria involves both comprehensive diagnostic criteria for
research and spine specialists, as well as easily applicable
algorithms that speed up referral to cervical spine MRI and spine
specialists. We have established an initial working group to act
upon this opportunity (AO Spine RECODE DCM Diagnostic Criteria
Incubator). If you are interested in contributing to this process,
please contact us.
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Fig. 1 Infographic providing an overview why diagnostic criteria for DCM are needed. The panels summarize shortcomings in patient care
and research which diagnostic criteria for DCM can help to overcome.
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